Historical record - last NADAC effective date: 4/19/2023

Product Information

OXYMORPHONE HCL 5 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.5201 per EA under NDC 13107010301. Its NADAC has been published 380 times since Jan 4, 2017.

FDA first approved this application on Apr 26, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXYMORPHONE HCL 5 MG TABLET

Oxymorphone Hydrochloride
$0.5201per EA
DEA Schedule CII

Strength

5 mg/1

NDC

13107010301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

4/19/2023

Active Ingredients

OXYMORPHONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204459

FDA Approved

4/26/2016

TE Code

AB

On Market Since

4/26/2016

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for OXYMORPHONE HCL 5 MG TABLET has been published 380 times since Jan 4, 2017, and over the history we have for it it has declined 64.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5201 per EA
All-time high$1.6929 (Jun 14, 2017)
All-time low$0.3420 (Sep 23, 2020)
Median price$0.6024
Average price$0.7510
Largest weekly change+123.9% (Dec 23, 2020)
Weeks tracked380
Tracking sinceJan 4, 2017

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

0.0%

5Y

+38.3%

All

-64.0%

Last surveyed Apr 10, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of OXYMORPHONE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXYMORPHONE HCL 5 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.5201 per EA (NDC 13107010301), effective Apr 10, 2024.

How has the price of OXYMORPHONE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXYMORPHONE HCL 5 MG TABLET has declined 64.0%. It has been tracked across 380 weekly CMS publications since Jan 4, 2017.

What are the highest and lowest recorded NADAC prices for OXYMORPHONE HCL 5 MG TABLET?

Since Jan 4, 2017, the NADAC for OXYMORPHONE HCL 5 MG TABLET has ranged from a low of $0.3420 (Sep 23, 2020) to a high of $1.6929 (Jun 14, 2017), with a median of $0.6024 per EA.

Are there cheaper alternatives to OXYMORPHONE HCL 5 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OXYMORPHONE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures OXYMORPHONE HCL 5 MG TABLET?

OXYMORPHONE HCL 5 MG TABLET (NDC 13107010301) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.